1/18/18 17:38 | 1/16/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.d | -1,850 | 28.03 | 0 | -66 | -72 | 25 | D | | | | | | | | | | | | | | |
1/18/18 17:38 | 1/16/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | M.d | 264 | 12.57 | 0 | 21 | 500 | 25 | D | | | | | | | | | | | | | | |
1/4/18 19:14 | 1/2/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.d | -823 | 21.64 | 0 | -38 | -35 | 70 | D | | | | | | | | | | | | | | |
1/4/18 19:14 | 1/2/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | M.d | 101 | 12.57 | 0 | 8 | 13 | 70 | D | | | | | | | | | | | | | | |
1/2/18 16:18 | 12/28/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | M.dm | 214 | 13.38 | 0 | 16 | 19 | 100 | D | | | | | | | | | | | | | | |
1/2/18 16:18 | 12/28/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.dm | -704 | 22.72 | 0 | -31 | -24 | 100 | D | | | | | | | | | | | | | | |
12/27/17 16:17 | 12/22/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S | -308 | 20.55 | 0 | -15 | -12 | 115 | D | | | | | | | | | | | | | | |
12/19/17 16:10 | 12/15/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S | -283 | 18.90 | 0 | -15 | -10 | 130 | D | | | | | | | | | | | | | | |
8/8/17 17:52 | 8/4/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.m | -278 | 18.57 | 0 | -15 | -9 | 153 | D | | | | | | | | | | | | | | |
5/3/17 17:17 | 5/1/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S | -31 | 16.61 | 1 | -2 | -1 | 168 | D | | | -1 | -6 | -16 | -12 | -2 | -2 | 3 | 4 | | | | |
4/28/17 18:12 | 4/26/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.m | -363 | 16.78 | 1 | -22 | -11 | 170 | D | | | 18 | -9 | -17 | -13 | -11 | 3 | 0 | -2 | | | | |
4/25/17 19:37 | 4/21/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.m | -190 | 16.78 | 2 | -11 | -6 | 184 | D | | | 19 | -11 | -22 | -23 | -12 | -6 | -1 | 1 | | | | |
4/21/17 16:31 | 4/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Dylan-Hyde Tyler | V8 | O | GC | S.m | -180 | 17.71 | 1 | -10 | -5 | 195 | D | | | | -18 | -19 | -17 | -8 | -13 | -2 | 0 | | | | |